Morgans names the best ASX 200 shares to buy in November

Morgans thinks that very strong returns could be on offer with these top ASX 200 shares.

| More on:
a woman holds a facebook like thumbs up sign high above her head. She has a very happy smile on her face.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Once a month, the team at Morgans picks out its best ASX share ideas.

These are the ASX shares that the broker thinks offer the highest risk-adjusted returns over a 12-month timeframe. They are also supported by a higher-than-average level of confidence.

Among its best ideas for the month of November are the two ASX 200 shares listed below. Here's what the broker is saying about them:

CSL Limited (ASX: CSL)

Morgans continues to rate this biotherapeutics giant as one of its best ideas. Especially after recent weakness means that CSL's shares are trading at a huge discount to historical levels. The broker appears to believe this could make now one of the best buying opportunities in a long time. It said:

While shares have struggled of late, we continue to view CSL as a key portfolio holding and sector pick, offering double-digit recovery in earnings growth as plasma collections increase, new products get approved and influenza vaccine uptake increases around ongoing concerns about respiratory viruses, with shares trading at 25x, a substantial discount (20%) to its long-term average.

Morgans has an add rating and a $328.20 price target on the company's shares.

ResMed Inc (ASX: RMD)

Another beaten-down ASX 200 share that the broker has on its best ideas list is ResMed. It believes the sleep treatment company is well-positioned for long-term growth despite the emergence of weight loss drugs like Ozempic. In light of this, it sees recent weakness as a buying opportunity. Morgans said:

While weight loss drugs have grabbed headlines and investor attention, we see these products having little impact on the large, underserved sleep disorder breathing market, and do not view them as category killers. Although quarters are likely to remain volatile, nothing changes our view that the company remains well placed and uniquely positioned as it builds a patient-centric, connected-care digital platform that addresses the main pinch points across the healthcare value chain.

The broker has an add rating and a $32.74 price target on ResMed's shares.

Motley Fool contributor James Mickleboro has positions in CSL and ResMed. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A cute little boy, short in height, wearing glasses, old-fashioned bow tie and cardigan stands against a wall near a tape measure with his hand at the top of his head as though to measure his height.
Broker Notes

Are ASX short sellers right about Pilbara Minerals shares?

Let's see what some of the big brokers think.

Read more »

A woman smiles at the outlook she sees through binoculars.
Investing Strategies

Profit up 24%: 2 classic ASX 200 stocks looking good for 2024

This pair has been a staple for many portfolios in the past, but experts reckon they're representing excellent value for…

Read more »

A woman looks over her shoulder towards the back seat while sitting at the wheel of a stationary car with a serious look on her face.
Cheap Shares

Down 23%, this ASX 200 stock is now ready for 'a turnaround story'

All companies encounter difficult periods, but if it's temporary then it's time for shrewd investors to swoop.

Read more »

A female executive smiles as she carries out business on her mobile phone.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

Read more »

Three satisfied miners with their arms crossed looking at the camera proudly
Resources Shares

Lithium, copper and gold stocks: Will they GO OFF IN 2024?

Bell Direct's Grady Wulff analyses the three hottest commodities to determine what their fortunes could be like next year.

Read more »

A group of people crowd around a guy sitting at a computer, and two plant kisses on his cheeks, the rest cheering.
Investing Strategies

2 'out of favour' ASX 200 shares that could make you serious money

DNR Capital's Jamie Nicol reveals there are 2 types of stocks you should buy right now.

Read more »

two men smiling with a laptop in front of them, symbolising a rising share price.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave the thumbs up to these ASX shares last week. Why are they bullish?

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Broker Notes

Brokers name 3 ASX shares to buy now

Here's why brokers are feeling bullish about these three shares this week.

Read more »